Agenda Topics- Cancer Personalised Medicine
- Companion Diagnostics
- Emerging Classes of Biomarkers for MDx
- Emerging technologies in MDx
- MDx for Infectious Diseases
- Next-Generation Sequencing: Its Impact on MDx
- Oncology Biomarkers
Sponsorship and Exhibition OpportunitiesExhibition Team, exhibitors@selectbio.com +44 (0) 1206 501654
|
Confirmed Speakers to date , , , , , , , , Holger Becker, Chief Scientific Officer, Microfluidic ChipShop GmbH Steve Blair, Professor, University of Utah Lilly Kong, Chief Scientific Officer, PrimeraDx Leanna Levine, Founder & CEO, ALine, Inc. Mao Mao, Research Fellow, Pfizer Global Research and Development Nicole Pamme, Professor in Analytical Chemistry, Stockholm University Natasha Paul, Senior Scientific Investigator, TriLink BioTechnologies Enal Razvi, Managing Director, Select Biosciences Inc Elena Schwartz, CSO, Ariadne Diagnostics LLC Jake Strzelecki, Director, Business Development, Biodesix Vladimir Tolstikov, Core Director, UC Davis Genome Center Jan Weile, Project Leader, Institute for Laboratory and Transfusion Medicine at the Heart and Diabetes Centre Robert Yamamoto, Founder, Zova Systems
|